You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Merck
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Last Updated: October 24, 2020

DrugPatentWatch Database Preview

ATROPINE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for atropine and what is the scope of patent protection?

Atropine is the generic ingredient in twenty-two branded drugs marketed by Meridian Medcl Techn, Abbvie, Rafa Labs Ltd, Us Army, Akorn, Alcon Labs Inc, Hospira, Fresenius Kabi Usa, Sebela Ireland Ltd, Scherer Rp, Medpointe Pharm Hlc, Hikma, Alpharma Us Pharms, Gd Searle Llc, Md Pharm, Able, Ani Pharms Inc, Ascot, Bayshore Pharms Llc, Fosun Pharma, Heather, Inwood Labs, Kv Pharm, Lannett, Leading Pharma Llc, Lederle, Mayne Pharma Inc, Mylan, Par Pharm, Parke Davis, Pvt Form, R And S Pharma, Roxane, Sun Pharm Industries, Upsher Smith Labs, Usl Pharma, Valeant Pharm Intl, Watson Labs, Vangard, Superpharm, Halsey, Mylan Institutional, Wyeth Ayerst, and Meridian Medcl, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for atropine. Two suppliers are listed for this compound.

Drug Prices for ATROPINE

See drug prices for ATROPINE

Recent Clinical Trials for ATROPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universiti Sains MalaysiaPhase 2
Cairo UniversityN/A
Fayoum UniversityPhase 1

See all ATROPINE clinical trials

US Patents and Regulatory Information for ATROPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Able DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 040395-001 Nov 27, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa ATROPINE SULFATE atropine sulfate SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL 209260-001 Jan 26, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
Mayne Pharma Inc DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 210789-001 Jun 3, 2020 AA RX No No   Start Trial   Start Trial   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-002 Jun 19, 2003 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Dow
Baxter
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.